Propanc Health Group Corp. (OTCQB: PPCH) is an emerging
healthcare company focused on the development of new and proprietary treatments
for cancer patients suffering from solid tumors, such as those resulting from
pancreatic, ovarian, and colorectal cancers. The company recently announced
results from studies for its lead product, PRP, confirming a synergistic
response to a broad range of cancer indications, including kidney, melanoma,
brain, prostate, liver, uterine and lung cancers. The data provides compelling
evidence that PRP has the potential to fight a broad range of cancer types,
some with significant unmet medical needs. The company will continue to
investigate PRP’s efficacy in these indications through clinical trials.
Moreover, data from the recent cell line studies tested at
the R&D facility of Propanc’s contract research partner, vivoPharm LLC,
which is headquartered in Hershey, Pennsylvania, showed a synergistic response
between the two active components, trypsinogen and chymotrypsinogen, further
strengthening its lead patent claims in key jurisdictions throughout North
America and Europe.
The company has also confirmed a scientific advice meeting
with the Medicines and Healthcare Products Regulatory Agency (MHRA) of the
United Kingdom, currently scheduled for the end of April. The purpose of the
meeting is to discuss Propanc’s ongoing development activities for PRP,
including preparation and structure of animal safety/toxicology studies and its
proposed early stage patient trials, together with supporting activities.
Propanc has developed a formulation of anti-cancer compounds
which exert a number of effects designed to control or prevent tumors from
recurring and spreading throughout the body. Its products involve or employ
proenzymes, which are inactive precursors of enzymes.
Learn more by visiting www.propanc.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment